Millennium Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Millennium Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-200,000	Closed	-$3.2M	–	3797
2016 Q1	$3.2M	Buy	+200,000	New	+$3.8M	0.01%	1518

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Millennium Management's INSY Position: Q2 2019 in Review

Millennium Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 812,262 shares — an estimated $3.75M sold.

Millennium Management first reported a position in INSY in Q3 2013 and held it in 20 quarters. The position peaked at $30M in Q3 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Millennium Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Millennium Management sold 812,262 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $3.75M.
Millennium Management first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 20 quarters.
Millennium Management's Insys Therapeutics, Inc. position peaked at $30M in Q3 2014.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.